These data are supported by murine models where CD4 T cells are efficient to control PTLD-like and Burkitt’s lymphoma even in the absence of CD8 T cells (Fu et al., 2004; Merlo et al., 2010). This evidence concerns the gene CD4 and Burkitt lymphoma.